Angela Corona

2.9k total citations
107 papers, 2.2k citations indexed

About

Angela Corona is a scholar working on Infectious Diseases, Molecular Biology and Virology. According to data from OpenAlex, Angela Corona has authored 107 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 85 papers in Infectious Diseases, 47 papers in Molecular Biology and 38 papers in Virology. Recurrent topics in Angela Corona's work include HIV/AIDS drug development and treatment (56 papers), HIV Research and Treatment (38 papers) and DNA and Nucleic Acid Chemistry (15 papers). Angela Corona is often cited by papers focused on HIV/AIDS drug development and treatment (56 papers), HIV Research and Treatment (38 papers) and DNA and Nucleic Acid Chemistry (15 papers). Angela Corona collaborates with scholars based in Italy, United States and Belgium. Angela Corona's co-authors include Enzo Tramontano, Francesca Esposito, Simona Distinto, Elias Maccioni, Rita Meleddu, Stefano Alcaro, Nicole Grandi, Elisa Fanunza, Giulia Bianco and Claudia Del Vecchio and has published in prestigious journals such as Nucleic Acids Research, PLoS ONE and Biochemistry.

In The Last Decade

Angela Corona

102 papers receiving 2.1k citations

Peers

Angela Corona
Chin‐Ho Chen United States
Ying Guo China
Norman C. Waters United States
Naheed Mahmood United Kingdom
Michael T. Flavin United States
Angela Corona
Citations per year, relative to Angela Corona Angela Corona (= 1×) peers Francesca Esposito

Countries citing papers authored by Angela Corona

Since Specialization
Citations

This map shows the geographic impact of Angela Corona's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Angela Corona with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Angela Corona more than expected).

Fields of papers citing papers by Angela Corona

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Angela Corona. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Angela Corona. The network helps show where Angela Corona may publish in the future.

Co-authorship network of co-authors of Angela Corona

This figure shows the co-authorship network connecting the top 25 collaborators of Angela Corona. A scholar is included among the top collaborators of Angela Corona based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Angela Corona. Angela Corona is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Richetta, Clémence, Olivier Delelis, Khursheed Ahmed, et al.. (2025). Identification of HIV-1 Reverse Transcriptase-Associated Ribonuclease H Inhibitors Based on 2-Hydroxy-1,4-naphthoquinone Mannich Bases. Molecules. 30(3). 495–495.
2.
Lupia, Antonio, Andrea Angeli, Filippo Cottiglia, et al.. (2025). Synthesis and Evaluation of Thiazolidinone-Isatin Hybrids for Selective Inhibition of Cancer-Related Carbonic Anhydrases. ACS Medicinal Chemistry Letters. 16(4). 560–566.
3.
Corona, Angela, Enzo Tramontano, Shuai Wang, et al.. (2024). Structure-Based Design of Novel Thiazolone[3,2-a]pyrimidine Derivatives as Potent RNase H Inhibitors for HIV Therapy. Molecules. 29(9). 2120–2120. 5 indexed citations
4.
Ambrosio, Francesca Alessandra, Giosuè Costa, Isabella Romeo, et al.. (2023). Targeting SARS-CoV-2 Main Protease: A Successful Story Guided by an In Silico Drug Repurposing Approach. Journal of Chemical Information and Modeling. 63(11). 3601–3613. 7 indexed citations
5.
Asthana, Abhishek, Angela Corona, Woo-Jin Shin, et al.. (2023). Analogs of the Catechol Derivative Dynasore Inhibit HIV-1 Ribonuclease H, SARS-CoV-2 nsp14 Exoribonuclease, and Virus Replication. Viruses. 15(7). 1539–1539. 5 indexed citations
6.
Nasr, Ibrahim S. Al, Angela Corona, Waleed S. Koko, et al.. (2023). Versatile anti-infective properties of pyrido- and dihydropyrido[2,3-d]pyrimidine-based compounds. Bioorganic & Medicinal Chemistry. 90. 117376–117376. 3 indexed citations
7.
Corona, Angela, Valentina Noemi Madia, Riccardo De Santis, et al.. (2023). Diketo acid inhibitors of nsp13 of SARS-CoV-2 block viral replication. Antiviral Research. 217. 105697–105697. 7 indexed citations
8.
Porcu, Stefania, Angela Corona, Daniele Chiriu, et al.. (2023). Visible Light-Mediated Inactivation of H1N1 Virus UsingPolymer-Based Heterojunction Photocatalyst. Polymers. 15(11). 2536–2536. 4 indexed citations
9.
Corona, Angela, et al.. (2023). Ebola virus disease: In vivo protection provided by the PAMP restricted TLR3 agonist rintatolimod and its mechanism of action. Antiviral Research. 212. 105554–105554. 2 indexed citations
10.
Corona, Angela, Elisa Fanunza, Cristiano Salata, et al.. (2022). Cynarin blocks Ebola virus replication by counteracting VP35 inhibition of interferon-beta production. Antiviral Research. 198. 105251–105251. 12 indexed citations
11.
Corona, Angela, David Schaller, Rainer Schobert, et al.. (2021). Garcinol from Garcinia indica inhibits HIV‐1 reverse transcriptase‐associated ribonuclease H. Archiv der Pharmazie. 354(9). e2100123–e2100123. 6 indexed citations
12.
Corona, Angela, Valentina Onnis, Claudia Del Vecchio, et al.. (2020). 2-(Arylamino)-6-(trifluoromethyl)nicotinic Acid Derivatives: New HIV-1 RT Dual Inhibitors Active on Viral Replication. Molecules. 25(6). 1338–1338. 11 indexed citations
13.
Esposito, Francesca, Francesca Alessandra Ambrosio, Giosuè Costa, et al.. (2019). Chromenone derivatives as a versatile scaffold with dual mode of inhibition of HIV-1 reverse transcriptase-associated Ribonuclease H function and integrase activity. European Journal of Medicinal Chemistry. 182. 111617–111617. 30 indexed citations
14.
Sanna, Cinzia, Daniela Rigano, Pierluigi Cortis, et al.. (2018). Onopordum illyricum L., a Mediterranean plant, as a source of anti HIV-1 compounds. Plant Biosystems - An International Journal Dealing with all Aspects of Plant Biology. 152(6). 1274–1281. 8 indexed citations
15.
Fanunza, Elisa, et al.. (2018). Chapter Four - Antiviral Agents Against Ebola Virus Infection: Repositioning Old Drugs and Finding Novel Small Molecules. 135–173. 1 indexed citations
16.
Poongavanam, Vasanthanathan, Angela Corona, Casper Steinmann, et al.. (2018). Structure-guided approach identifies a novel class of HIV-1 ribonuclease H inhibitors: binding mode insights through magnesium complexation and site-directed mutagenesis studies. MedChemComm. 9(3). 562–575. 14 indexed citations
18.
Costa, Giosuè, Roberta Rocca, Angela Corona, et al.. (2018). Novel natural non-nucleoside inhibitors of HIV-1 reverse transcriptase identified by shape- and structure-based virtual screening techniques. European Journal of Medicinal Chemistry. 161. 1–10. 28 indexed citations
19.
Meleddu, Rita, Simona Distinto, Roberto Cirilli, et al.. (2017). Through scaffold modification to 3,5-diaryl-4,5-dihydroisoxazoles: new potent and selective inhibitors of monoamine oxidase B. Journal of Enzyme Inhibition and Medicinal Chemistry. 32(1). 264–270. 15 indexed citations
20.
Meleddu, Rita, Simona Distinto, Angela Corona, et al.. (2016). Exploring the thiazole scaffold for the identification of new agents for the treatment of fluconazole resistant Candida. Journal of Enzyme Inhibition and Medicinal Chemistry. 31(6). 1672–1677. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026